Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

N-(3'-(Dimethylamino)propyl)amides based on 18βH-glycyrrhetinic acid retain P-glycoprotein inhibitory and MDR-reversing activities.

Multidrug resistance (MDR) is a major obstacle to successful cancer chemotherapy, primarily mediated by P-glycoprotein (P-gp/ABCB1), which actively effluxes structurally unrelated anticancer drugs. We previously reported Sol-DMAP, an 18βH-glycyrrhetinic acid-derived P-gp inhibitor that reverses chemoresistance and exhi...

A. Moralev, Nika V. Konoreva, O. Salomatina et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.